Rituximab versus Tocilizumab in anti-TNF inadequate responder patients with Rheumatoid Arthritis (R4RA): a stratified, biopsy-driven, multi-centre, randomised, open label, controlled clinical trial – 16 week outcomes

Frances  Humby; Patrick Durez; Maya Buch; Myles J Lewis; Hasan Rizvi; Felice Rivellese; Alessandra Nerviani; Giovanni Giorli; Arti Mahto; Carlomaurizio Montecucco; Bernard R Lauwerys; Nora Ng; Pauline Ho; Michele Bombardieri; Vasco C Romão; P Verschueren; Stephen Kelly; Pier Paolo Sainaghi; Nagui Gendi; Bhaskar Dasgupta; Alberto Cauli; Piero Reynolds; Juan D Cañete; R Moots; Taylor Peter; Christopher J Edwards; John Isaacs; Peter Sasieni; Ernest Choy; Costantino Pitzalis

Rituximab versus Tocilizumab in anti-TNF inadequate responder patients with Rheumatoid Arthritis (R4RA): a stratified, biopsy-driven, multi-centre, randomised, open label, controlled clinical trial – 16 week outcomes

Frances Humby
, Patrick Durez
, Maya Buch
, Myles J Lewis
, Hasan Rizvi
, Felice Rivellese
, Alessandra Nerviani
, Giovanni Giorli
, Arti Mahto
, Carlomaurizio Montecucco
, Bernard R Lauwerys
, Nora Ng
, Pauline Ho
, Michele Bombardieri
, Vasco C Romão
, P Verschueren
, Stephen Kelly
, Pier Paolo Sainaghi
, Nagui Gendi
, Bhaskar Dasgupta

Alberto Cauli, Piero Reynolds, Juan D Cañete, R Moots, Taylor Peter, Christopher J Edwards, John Isaacs, Peter Sasieni, Ernest Choy, Costantino Pitzalis

Division of Musculoskeletal & Dermatological Sciences (L5)

Queen Mary University of London

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	The Lancet
Publication status	Published - 2020

Embargoed Document

R4RA_RCT_ The Lancet_141020_Clean
Accepted author manuscript, 260 KB
Embargo ends: 08/11/2030 00:00 GMT

Cite this

Humby, F., Durez, P., Buch, M., Lewis, M. J., Rizvi, H., Rivellese, F., Nerviani, A., Giorli, G., Mahto, A., Montecucco, C., Lauwerys, B. R., Ng, N., Ho, P., Bombardieri, M., Romão, V. C., Verschueren, P., Kelly, S., Sainaghi, P. P., Gendi, N., ... Pitzalis, C. (2020). Rituximab versus Tocilizumab in anti-TNF inadequate responder patients with Rheumatoid Arthritis (R4RA): a stratified, biopsy-driven, multi-centre, randomised, open label, controlled clinical trial – 16 week outcomes. The Lancet.

@article{83fa0bc4a0f8433b9b2c6bb2a94f335e,

title = "Rituximab versus Tocilizumab in anti-TNF inadequate responder patients with Rheumatoid Arthritis (R4RA): a stratified, biopsy-driven, multi-centre, randomised, open label, controlled clinical trial {\textendash} 16 week outcomes",

author = "Frances Humby and Patrick Durez and Maya Buch and Lewis, \{Myles J\} and Hasan Rizvi and Felice Rivellese and Alessandra Nerviani and Giovanni Giorli and Arti Mahto and Carlomaurizio Montecucco and Lauwerys, \{Bernard R\} and Nora Ng and Pauline Ho and Michele Bombardieri and Rom{\~a}o, \{Vasco C\} and P Verschueren and Stephen Kelly and Sainaghi, \{Pier Paolo\} and Nagui Gendi and Bhaskar Dasgupta and Alberto Cauli and Piero Reynolds and Ca{\~n}ete, \{Juan D\} and R Moots and Taylor Peter and Edwards, \{Christopher J\} and John Isaacs and Peter Sasieni and Ernest Choy and Costantino Pitzalis",

year = "2020",

language = "English",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier BV",

}

Humby, F, Durez, P, Buch, M, Lewis, MJ, Rizvi, H, Rivellese, F, Nerviani, A, Giorli, G, Mahto, A, Montecucco, C, Lauwerys, BR, Ng, N, Ho, P, Bombardieri, M, Romão, VC, Verschueren, P, Kelly, S, Sainaghi, PP, Gendi, N, Dasgupta, B, Cauli, A, Reynolds, P, Cañete, JD, Moots, R, Peter, T, Edwards, CJ, Isaacs, J, Sasieni, P, Choy, E & Pitzalis, C 2020, 'Rituximab versus Tocilizumab in anti-TNF inadequate responder patients with Rheumatoid Arthritis (R4RA): a stratified, biopsy-driven, multi-centre, randomised, open label, controlled clinical trial – 16 week outcomes', The Lancet.

TY - JOUR

T1 - Rituximab versus Tocilizumab in anti-TNF inadequate responder patients with Rheumatoid Arthritis (R4RA): a stratified, biopsy-driven, multi-centre, randomised, open label, controlled clinical trial – 16 week outcomes

AU - Humby, Frances

AU - Durez, Patrick

AU - Buch, Maya

AU - Lewis, Myles J

AU - Rizvi, Hasan

AU - Rivellese, Felice

AU - Nerviani, Alessandra

AU - Giorli, Giovanni

AU - Mahto, Arti

AU - Montecucco, Carlomaurizio

AU - Lauwerys, Bernard R

AU - Ng, Nora

AU - Ho, Pauline

AU - Bombardieri, Michele

AU - Romão, Vasco C

AU - Verschueren, P

AU - Kelly, Stephen

AU - Sainaghi, Pier Paolo

AU - Gendi, Nagui

AU - Dasgupta, Bhaskar

AU - Cauli, Alberto

AU - Reynolds, Piero

AU - Cañete, Juan D

AU - Moots, R

AU - Peter, Taylor

AU - Edwards, Christopher J

AU - Isaacs, John

AU - Sasieni, Peter

AU - Choy, Ernest

AU - Pitzalis, Costantino

PY - 2020

Y1 - 2020

M3 - Article

SN - 0140-6736

JO - The Lancet

JF - The Lancet

ER -